This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

FutureFuel Releases Second Quarter 2013 Results

Income from operations increased from $11,572,000 in the three months ended June 30, 2012 to $24,975,000 in the three months ended June 30, 2013. FutureFuel does not report income from operations by segment, but does report segment gross profit. The chemicals segment gross profit increased 31% to $14,784,000 in the three months ended June 30, 2013 from $11,249,000 in the three month ended June 30, 2012. Biofuels segment gross profit increased to $12,842,000 in the three months ended June 30, 2013 from $3,151,000 in the three months ended June 30, 2012. Market conditions were more favorable for biodiesel in 2013 as compared to 2012 largely as a result of the reinstatement of the $1.00 blenders credit in January 2013. Biodiesel profitability in the second quarter of 2012 was negatively impacted due to our inventory of unsold, internally generated RINs. At June 30, 2013 we maintained a minimal inventory of RINs. Also impacting Biofuels gross profit were hedging gains. For the second quarter of 2013 hedging gains totaled $2,327,000 down from a gain of $8,473,000 in the second quarter of 2012.  Chemical segment gross profit increased primarily as a result of three factors. First, the improved economies of scale on fixed resources from the addition of new chemical products and, to a greater degree, continued increased biodiesel production. Second, improved profit from the bleach activator business as the sales price has increased on the customer's reduced sales demands. Lastly, profit improved with the variation in the product mix sold.

Net income increased from $8,473,000, or $0.20 per diluted share, for the second quarter of 2012 compared with $18,156,000 or $0.42 per diluted share for the second quarter of 2013. This increase was the net result of the factors noted above. Adjusted EBITDA totaled $25,340,000 in the second quarter of 2013 as compared to $5,940,000 in the second quarter of 2012. 

Six Month Financial and Business Summary

Revenues for the six months ended June 30, 2013 were $198,228,000 as compared to revenues for the six months ended June 30, 2012 of $188,964,000, an increase of 5%. Revenues from biofuels increased 6% and accounted for 59% of total revenues in the first six months of 2013 as compared to 58% in the first six months of 2012. Revenues from chemicals increased 4% and accounted for 41% of total revenues in the first six months of 2013 as compared to 42% in the first six months of 2012. Revenue from the bleach activator and the proprietary herbicide and intermediates are together the most significant components of our chemicals business revenue base, accounting for 20% of total revenues for the six months ended June 30, 2013 as compared to 23% of total revenues for the six months ended June 30, 2012. These products comprised a smaller percentage of our total revenues in 2013 as revenues from our other custom products have assumed a larger percentage coupled with decreases in the sales of the bleach activator and the proprietary herbicide and intermediates. Revenues from biofuels increased from $109,662,000 in the six months ended June 30, 2012 to $116,066,000 in the six months ended June 30, 2013. The reinstatement of the $1.00 per gallon federal blenders credit in January 2013 along with the government mandated renewable fuel standard for biodiesel combined to improve the economics of biodiesel in 2013. Revenues from biofuels have also been impacted by our sales of refined petroleum products as a supplier on a common carrier pipeline. Such gross sales totaled $8,881,000 in the first six months of 2012 compared to $9,213,000 in the first six of 2013. Such sales generate little gross profit.

2 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs